Archives
- 2018-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-07
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
- 2024-12
- 2025-01
- 2025-02
- 2025-03
- 2025-04
- 2025-05
- 2025-06
- 2025-09
- 2025-10
-
CHIR 99021 Trihydrochloride: Precision Engineering of Org...
2025-10-01
Explore how CHIR 99021 trihydrochloride, a potent GSK-3 inhibitor, enables precise modulation of stem cell maintenance and differentiation in organoid systems. This article uniquely dissects the interplay between serine/threonine kinase inhibition, controlled cell fate, and advanced metabolic disease research.
-
Gastrin I (Human): Catalyzing Precision in GI Physiology ...
2025-09-30
Explore how Gastrin I (human) is redefining the study of gastric acid secretion, CCK2 receptor signaling, and gastrointestinal disorder modeling. This thought-leadership article integrates mechanistic insight with strategic guidance for translational researchers, emphasizing the peptide’s transformative role in organoid-based systems and its translational relevance for drug discovery and disease modeling.
-
Oxaliplatin in Precision Oncology: Mechanisms and Next-Ge...
2025-09-29
Explore Oxaliplatin’s advanced mechanistic action as a platinum-based chemotherapeutic agent and its transformative role in modern preclinical assembloid models. Gain unique insights into apoptosis induction via DNA damage and implications for personalized metastatic colorectal cancer therapy.
-
Gefitinib (ZD1839): Mechanisms, Advanced Tumor Models, an...
2025-09-28
Explore the advanced scientific basis of Gefitinib (ZD1839), a selective EGFR tyrosine kinase inhibitor, and its transformative role in cancer research. This in-depth article uniquely examines EGFR pathway inhibition in complex tumor microenvironments and the future of personalized therapy.
-
Annexin V-Cy5PI Apoptosis Kit
2025-06-03
-
Live-Dead Cell Staining Kit I (Calcein AMPI)
2025-05-30
-
EZ Cap Mito-EGFP Probe mRNA (m1Ψ)
2025-05-29
-
5-Formyl-UTP
2025-05-29
-
Caspase-3 Colorimetric Assay Kit
2025-05-29
-
Cy3 TSA Fluorescence System Kit
2025-05-27
-
Streptavidin - Cy3
2025-05-27
-
AOPI Double Staining Kit
2025-05-26
-
5-Formyl-UTP
2025-05-26
-
Cy5 Goat Anti-Mouse IgG (H+L) Antibody
2025-05-24
-
mCherry circRNA
2025-05-23